Metformin through inhibition of NF-κB signaling pathway enhanced sensitivity to standard chemotherapeutics in both sensitive and resistant cell linesAurora-A kinase inhibitor. Its use in ovarian cancer cell lines caused cell cycle arrest, inhibition of NF-κB signaling, and cytokine secretion. Here, NFKB1 is linked to ovarian cancer.